Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan

被引:37
|
作者
Koike, Teruaki
Tsuchiya, Ryosuke
Goya, Tomoyuki
Sohara, Yasunori
Miyaoka, Etsuo
机构
[1] Niigata Canc Ctr Hosp, Div Chest Surg, Japanese Joint Comm Lung Canc Registrat, Niigata 9518566, Japan
[2] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan
[3] Kyorin Univ, Dept Surg, Mitaka, Tokyo, Japan
[4] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi, Japan
[5] Tokyo Univ Sci, Dept Math, Japanese Joint Comm Lung Canc Registrat, Tokyo 162, Japan
关键词
clinical stage I lung cancer; survival; prognostic factor; limited pulmonary resection; maximum tumor diameter;
D O I
10.1097/01.JTO.0000268674.02744.f9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The objective of this retrospective study was to identify prognostic factors in completely resected clinical (c-) stage I non-small cell lung cancer cases. Methods: In 2001, the Japanese Joint Committee of Lung Cancer Registry collected data on the outcome and clinicopathological profiles of 7408 patients who had undergone resection for primary lung cancer in 1994. They included 3315 c-stage I patients who underwent complete resection, and in this study attempted to identify prognostic factors in the c-stage IA and c-stage IB cases. Results: The overall 5-year survival rate was 66.5%: 74.7% in the 2085 c-stage IA cases and 52.5% in the 1230 c-stage IB cases. The survival curve of the c-stage IA cases was higher than that of the c-stage IB cases. Multivariate analysis of the c-stage IA cases revealed six factors that predicted a significantly better outcome: age, gender, pathological (p-) T status, p-N status, nodal dissection, and tumor diameter (: 2 cm), and the same analysis of the c-stage IB cases revealed six factors: age, gender, p-T status, p-N status operative procedure, and tumor diameter (< 5 cm). The c-stage I patients whose tumor diameter was 2 cm or less had a higher survival rate than the patients whose turner diameter was more than 2 cm, and the c-stage IB patients whose tumor diameter was less than 5 cm had a higher survival rate than the patients whose tumor diameter was 5 cm or more. Conclusion: Tumor size is an independent prognostic factor for postoperative survival in c-stage 1 patients.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [31] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients with Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
    Feng, Wen
    Li, Yuan
    Fu, Xiaolong
    Shen, Lei
    Cai, Xuwei
    Zhu, Zhengfei
    Chang, Jianhua
    Xiang, Jiaqing
    Zhang, Yawei
    Chen, Haiquan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [32] Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer
    Schuchert, Matthew J.
    Normolle, Daniel P.
    Awais, Omar
    Pennathur, Arjun
    Wilson, David O.
    Luketich, James D.
    Landreneau, Rodney J.
    LUNG CANCER, 2019, 128 : 145 - 151
  • [33] Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer
    Kumagai, Shogo
    Marumo, Satoshi
    Arita, Machiko
    Yamanashi, Keiji
    Sumitomo, Ryota
    Otake, Yosuke
    Shoji, Tsuyoshi
    Fukui, Motonari
    Katayama, Toshiro
    Okumura, Norihito
    Huang, Cheng-Long
    BMC PULMONARY MEDICINE, 2017, 17
  • [34] Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer
    Ju, Lixia
    Han, Mingquan
    ONCOLOGY LETTERS, 2016, 12 (01) : 731 - 733
  • [35] Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
    Wu, Ching-Feng
    Fu, Jui-Ying
    Yeh, Chi-Ju
    Liu, Yun-Hen
    Hsieh, Ming-Ju
    Wu, Yi-Cheng
    Wu, Ching-Yang
    Tsai, Ying-Huang
    Chou, Wen-Chi
    MEDICINE, 2015, 94 (32)
  • [36] Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Chou, Teh-Ying
    Lin, Shiou-Fu
    Wu, Yu-Chung
    CHEST, 2012, 142 (01) : 141 - 150
  • [37] Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
    Reinmuth, N
    Brandt, B
    Semik, M
    Kunze, WP
    Achatzy, R
    Scheld, HH
    Broermann, P
    Berdel, WE
    Macha, HN
    Thomas, M
    LUNG CANCER, 2002, 36 (03) : 265 - 270
  • [38] Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer
    Wu, Xiao-Tian
    Zhou, Jian-Wei
    Pan, Long-Ci
    Ge, Ting
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (05)
  • [39] Clinical and Molecular Predictors of Recurrence in Stage I Non-Small Cell Lung Cancer
    Starnes, Sandra L.
    Pathrose, Peterson
    Wang, Jiang
    Succop, Paul
    Morris, John C.
    Bridges, James
    Kupert, Elena Y.
    Anderson, Marshall
    ANNALS OF THORACIC SURGERY, 2012, 93 (05): : 1606 - 1613
  • [40] Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences
    Ustaalioglu, Bala Basak Oven
    Unal, Olcun Umit
    Turan, Nedim
    Bilici, Ahmet
    Kaya, Serap
    Eren, Tulay
    Ulas, Arife
    Inal, Ali
    Berk, Veli
    Demirci, Umut
    Alici, Suleyman
    Bal, Oznur
    Benekli, Mustafa
    Gumus, Mahmut
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6287 - 6292